Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 2
1977 2
1978 4
1979 2
1980 6
1981 8
1982 17
1983 17
1984 11
1985 15
1986 14
1987 10
1988 16
1989 13
1990 19
1991 21
1992 21
1993 20
1994 10
1995 15
1996 14
1997 7
1998 6
1999 10
2000 5
2001 7
2002 14
2003 6
2004 2
2005 7
2006 11
2007 13
2008 10
2009 10
2010 8
2011 6
2012 16
2013 12
2014 14
2015 31
2016 28
2017 38
2018 49
2019 69
2020 76
2021 70
2022 55
2023 73
2024 25

Text availability

Article attribute

Article type

Publication date

Search Results

858 results

Results by year

Filters applied: . Clear all
Page 1
Vaginal laser therapy for gynecologic conditions: re-examining the controversy and where do we go from here.
Zipper R, Lamvu G. Zipper R, et al. J Comp Eff Res. 2022 Aug;11(11):843-851. doi: 10.2217/cer-2021-0281. Epub 2022 Jun 21. J Comp Eff Res. 2022. PMID: 35726603 Free article. Review.
Despite significant controversy, vaginal laser therapy continues to be used for treatment of many gynecologic and pelvic conditions including vaginal atrophy, vaginal dryness, dyspareunia, urinary incontinence and pelvic pain. This commentary re …
Despite significant controversy, vaginal laser therapy continues to be used for treatment of many gynecologic and pelvi …
[Vaginal laser therapy-myths and facts].
Hampel C. Hampel C. Urologie. 2023 Feb;62(2):132-140. doi: 10.1007/s00120-022-02012-1. Epub 2023 Jan 10. Urologie. 2023. PMID: 36625941 Review. German.
The current guideline "Female Urinary Incontinence" of the working group of scientific medical professional associations (AWMF) comprises a recommendation about the optional use of vaginal laser therapy in patients with mild to moderate stress urinary inconti …
The current guideline "Female Urinary Incontinence" of the working group of scientific medical professional associations (AWMF) comprises a …
Laser therapy for the restoration of vaginal function.
Gambacciani M, Palacios S. Gambacciani M, et al. Maturitas. 2017 May;99:10-15. doi: 10.1016/j.maturitas.2017.01.012. Epub 2017 Feb 4. Maturitas. 2017. PMID: 28364861 Review.
Laser therapy has a therapeutic role in various medical conditions and most recently has gained interest as a non-hormonal treatment for genitourinary syndrome of menopause (GSM) and as a non-invasive option for stress urinary incontinence (SUI). Several therapies a
Laser therapy has a therapeutic role in various medical conditions and most recently has gained interest as a non-hormonal tre
Vaginal Laser Therapy for Female Stress Urinary Incontinence: New Solutions for a Well-Known Issue-A Concise Review.
Ruffolo AF, Braga A, Torella M, Frigerio M, Cimmino C, De Rosa A, Sorice P, Castronovo F, Salvatore S, Serati M. Ruffolo AF, et al. Medicina (Kaunas). 2022 Apr 4;58(4):512. doi: 10.3390/medicina58040512. Medicina (Kaunas). 2022. PMID: 35454351 Free PMC article. Review.
The aim of this review is to narratively report the efficacy and safety of new mini-invasive solutions for SUI treatment as laser energy devices, in particular, the microablative fractional carbon dioxide laser and the non-ablative Erbium-YAG laser. ...Additi …
The aim of this review is to narratively report the efficacy and safety of new mini-invasive solutions for SUI treatment as laser ene …
Vaginal laser therapy for GSM/VVA: where we stand now - a review by the EUGA Working Group on Laser.
Salvatore S, Ruffolo AF, Phillips C, Athanasiou S, Cardozo L, Serati M; EUGA Working Group. Salvatore S, et al. Climacteric. 2023 Aug;26(4):336-352. doi: 10.1080/13697137.2023.2225766. Epub 2023 Jul 3. Climacteric. 2023. PMID: 37395104 Review.
Due to the chronic progressive trend of GSM, symptoms tend to reappear after the cessation of therapy, and frequently long-term treatment is required. First-line therapies include vulvar and vaginal lubricant or moisturizers, and, in the case of failure, low-dose …
Due to the chronic progressive trend of GSM, symptoms tend to reappear after the cessation of therapy, and frequently long-term treat …
Vaginal laser therapy for genitourinary syndrome of menopause - systematic review.
Mension E, Alonso I, Tortajada M, Matas I, Gómez S, Ribera L, Anglès S, Castelo-Branco C. Mension E, et al. Maturitas. 2022 Feb;156:37-59. doi: 10.1016/j.maturitas.2021.06.005. Epub 2021 Jun 20. Maturitas. 2022. PMID: 34217581
Despite that, there has been an increase in the use of vaginal laser therapy globally over the last decade. OBJECTIVE: The objective of this review is to evaluate the literature which assesses the efficacy and safety of the vaginal laser ther
Despite that, there has been an increase in the use of vaginal laser therapy globally over the last decade. OBJECTIVE: …
[Vaginal laser therapy for urinary incontinence and genitourinary syndrome of menopause : A review].
Ratz C. Ratz C. Urologe A. 2019 Mar;58(3):284-290. doi: 10.1007/s00120-019-0861-1. Urologe A. 2019. PMID: 30721329 Review. German.
BACKGROUND: Use of vaginal laser therapy in the treatment of grade I stress urinary incontinence and genitourinary syndrome of menopause is gaining in importance across the globe. ...CONCLUSIONS: Vaginal laser therapy has shown potential …
BACKGROUND: Use of vaginal laser therapy in the treatment of grade I stress urinary incontinence and genitourinary synd …
CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis.
Filippini M, Porcari I, Ruffolo AF, Casiraghi A, Farinelli M, Uccella S, Franchi M, Candiani M, Salvatore S. Filippini M, et al. J Sex Med. 2022 Mar;19(3):452-470. doi: 10.1016/j.jsxm.2021.12.010. Epub 2022 Jan 29. J Sex Med. 2022. PMID: 35101378
This study is registered on PROSPERO, number CRD42021238121. OUTCOMES: Effects of CO2-Laser therapy on GSM symptoms assessed through subjective or objective efficacy measurement methods. ...Filippini M, Porcari I, Ruffolo AF, et al., CO2-Laser therapy
This study is registered on PROSPERO, number CRD42021238121. OUTCOMES: Effects of CO2-Laser therapy on GSM symptoms assessed t …
New Innovations for the Treatment of Vulvovaginal Atrophy: An Up-to-Date Review.
Benini V, Ruffolo AF, Casiraghi A, Degliuomini RS, Frigerio M, Braga A, Serati M, Torella M, Candiani M, Salvatore S. Benini V, et al. Medicina (Kaunas). 2022 Jun 6;58(6):770. doi: 10.3390/medicina58060770. Medicina (Kaunas). 2022. PMID: 35744033 Free PMC article. Review.
The currently available therapies include vaginal lubricants and moisturizers, vaginal estrogens and dehydroepiandrosterone (DHEA), systemic hormone therapy, and Ospemifene. ...The aim of this review is to report up-to-date efficacy and safety data of lase
The currently available therapies include vaginal lubricants and moisturizers, vaginal estrogens and dehydroepiandrosterone (D …
Vaginal laser therapy versus hyaluronic acid suppositories for women with symptoms of urogenital atrophy after treatment for breast cancer: A randomized controlled trial.
Gold D, Nicolay L, Avian A, Greimel E, Balic M, Pristauz-Telsnigg G, Tamussino K, Trutnovsky G. Gold D, et al. Maturitas. 2023 Jan;167:1-7. doi: 10.1016/j.maturitas.2022.08.013. Epub 2022 Sep 9. Maturitas. 2023. PMID: 36279690 Free article. Clinical Trial.
RESULTS: Of the 43 women who participated, 22 were randomized to intravaginal laser therapy, and 21 to vaginal suppositories. At 3 months score on the Vaginal Health Index had improved significantly in both groups (p = 0.001), without a significant dif …
RESULTS: Of the 43 women who participated, 22 were randomized to intravaginal laser therapy, and 21 to vaginal supposit …
858 results